Status:
UNKNOWN
Evaluation of the Impact of the Use of NewSpringForMe on Transplanted Patients' Quality of Life and Support
Lead Sponsor:
Fonds de Dotation HTC Project
Collaborating Sponsors:
Saint-Louis Hospital, Paris, France
Nutricia Nutrition Clinique
Conditions:
Hematologic Diseases
Bone Marrow Transplantation
Eligibility:
All Genders
18+ years
Brief Summary
Bone marrow transplantation is both a great treatment for patients with hematological diseases. It is also one of the only hopes of staying alive by "starting from scratch". It is a trying life experi...
Detailed Description
Each year in France, nearly 2,000 patients, adults and children of all ages, are treated by bone marrow transplantation, the last therapeutic resort to treat and cure serious blood diseases, malignant...
Eligibility Criteria
Inclusion
- Inclusion criteria :
- at least 18 years old
- with a first indication for allograft bone marrow or Peripheric Stem Cells
- monitored by the adult hematology transplant department St-Louis Hospital
- having signed the consent
- affiliated to a social security scheme
- able to understand the objectives of the study and to use a digital tool
- Exclusion criteria :
- aged under 18
- with an indication of second or third allograft
- not being affiliated to a social security scheme
Exclusion
Key Trial Info
Start Date :
September 27 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
170 Patients enrolled
Trial Details
Trial ID
NCT06148610
Start Date
September 27 2022
End Date
December 31 2024
Last Update
November 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service Hématologie Greffe Trèfle 3, Hôpital Saint-Louis, AP-HP
Paris, France, 75010